[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Citrotech Inc (CITR)

Citrotech Inc (CITR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
CitroTech Attracts Wildfire Defense Partnerships Across North America's Most Fire-Prone Regions

The company has grown its certified partner network to more than a dozen organizations, extending access to proactive wildfire protection in high-risk communities

CITR : 5.91 (-1.34%)
All Risk Shield Chooses to Apply CitroTech Following Independent Testing of Legacy Wildfire Defense Products

Firefighter-led wildfire mitigation company cites crew safety, environmental stewardship, and operational considerations as key factors in selection

CITR : 5.91 (-1.34%)
CitroTech Expands Patent Portfolio, Leading the Market for GPS-Verified, AI-Enabled Deployment of Eco-Friendly Fire Retardants

Company's 31 issued patents include GPS tracking and network-connected databases that generate auditable, coordinate-stamped records of fire-retardant applications

CITR : 5.91 (-1.34%)
CitroTech Inc. to Participate in June Investor Conferences

CEO Wes Bolsen Discusses Commercialization Progress and Future Value Catalysts in Recent Interview on Planet MicroCap Podcast

CITR : 5.91 (-1.34%)
CitroTech Q1 Earnings Call Highlights

CitroTech (NYSEAMERICAN:CITR) used its first-quarter 2026 earnings call to frame the company’s transition from technology validation toward early commercial deployment across wildfire prevention, fire-resistant...

CITR : 5.91 (-1.34%)
CitroTech Provides Business Update

Highlights Operational Readiness and Growing Engagement from Customers and Partners Hexion Joint Venture Enhances Commercial Pathway and Expands Industry Reach ...

CITR : 5.91 (-1.34%)
CitroTech Partners With Texas A&M Engineering Experiment Station to Advance Safer, High-Performance Fire-Resistant Textiles

Collaboration aims to bring wash-durable, water-based polymer technology from lab to real-world use, expanding fire protection across critical applications

CITR : 5.91 (-1.34%)
CitroTech to Host First Quarter 2026 Financial Results Conference Call on May 15, 2026

CitroTech Inc. (NYSE AM: CITR), a leading specialty chemical company delivering environmentally-safe fire inhibitor solutions, today announced that management will host a conference call on Friday, May...

CITR : 5.91 (-1.34%)
New to The Street to Air Show #747 Tonight on Fox Business Network Featuring Performance Golf, CitroTech, Lee Gause, CISO Global, and Lost Soldier Oil and Gas

The show broadcasts as sponsored programming and features integrated TV commercial sponsorships from Synergy CHC Corp. (NASDAQ:SNYR), CISO Global Inc. (NASDAQ:CISO), Virtuix Holdings Inc. (NASDAQ:VTIX),...

SNYR : 0.2147 (+3.72%)
IGC : 0.2796 (-0.46%)
VTIX : 2.98 (-1.00%)
DVLT : 0.3967 (+3.28%)
CITR : 5.91 (-1.34%)
CISO : 0.2867 (+0.46%)
Equus Announces Fourth Quarter Net Asset Value

HOUSTON, April 21, 2026 (GLOBE NEWSWIRE) -- Equus Total Return, Inc. (NYSE: EQS)  (“Equus” or the “Company”) reports net assets as of December 31, 2025, of $16.6 million. Net asset value per...

EQS : 1.2000 (-2.44%)
CITR : 5.91 (-1.34%)

Barchart Exclusives

This Little-Known Stock Has Surged 550% in the Past Year
SELLAS Life Sciences (SLS) has surged 550% in the past year, driven by technical momentum and speculative trading. SLS currently has no revenue, with all products in development or clinical trials, making the stock highly speculative. Technical indicators are overwhelmingly bullish, but high short interest highlights significant risk. Sentiment is... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.